1. Home
  2. TCI vs ELDN Comparison

TCI vs ELDN Comparison

Compare TCI & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • ELDN
  • Stock Information
  • Founded
  • TCI 1983
  • ELDN 2004
  • Country
  • TCI United States
  • ELDN United States
  • Employees
  • TCI N/A
  • ELDN N/A
  • Industry
  • TCI Real Estate
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • ELDN Health Care
  • Exchange
  • TCI Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • TCI 257.5M
  • ELDN 288.5M
  • IPO Year
  • TCI N/A
  • ELDN N/A
  • Fundamental
  • Price
  • TCI $28.52
  • ELDN $4.02
  • Analyst Decision
  • TCI
  • ELDN Strong Buy
  • Analyst Count
  • TCI 0
  • ELDN 1
  • Target Price
  • TCI N/A
  • ELDN $16.00
  • AVG Volume (30 Days)
  • TCI 4.3K
  • ELDN 538.0K
  • Earning Date
  • TCI 11-07-2024
  • ELDN 11-12-2024
  • Dividend Yield
  • TCI N/A
  • ELDN N/A
  • EPS Growth
  • TCI N/A
  • ELDN N/A
  • EPS
  • TCI 0.37
  • ELDN N/A
  • Revenue
  • TCI $49,821,000.00
  • ELDN N/A
  • Revenue This Year
  • TCI N/A
  • ELDN N/A
  • Revenue Next Year
  • TCI N/A
  • ELDN N/A
  • P/E Ratio
  • TCI $77.82
  • ELDN N/A
  • Revenue Growth
  • TCI 4.46
  • ELDN N/A
  • 52 Week Low
  • TCI $26.29
  • ELDN $1.52
  • 52 Week High
  • TCI $43.40
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • TCI 50.23
  • ELDN 45.29
  • Support Level
  • TCI $27.00
  • ELDN $3.68
  • Resistance Level
  • TCI $27.90
  • ELDN $4.19
  • Average True Range (ATR)
  • TCI 0.89
  • ELDN 0.33
  • MACD
  • TCI -0.15
  • ELDN -0.05
  • Stochastic Oscillator
  • TCI 34.00
  • ELDN 26.15

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: